Uehara, T., Choong, C., Nakamori, M., Hayakawa, H., Nishiyama, K., Kasahara, Y., . . . Mochizuki, H. (2019). Amido-bridged nucleic acid (AmNA)-modified antisense oligonucleotides targeting α-synuclein as a novel therapy for Parkinson’s disease. Sci Rep.
Citação norma ChicagoUehara, Takuya, et al. "Amido-bridged Nucleic Acid (AmNA)-modified Antisense Oligonucleotides Targeting α-synuclein As a Novel Therapy for Parkinson’s Disease." Sci Rep 2019.
ציטוט MLAUehara, Takuya, et al. "Amido-bridged Nucleic Acid (AmNA)-modified Antisense Oligonucleotides Targeting α-synuclein As a Novel Therapy for Parkinson’s Disease." Sci Rep 2019.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.